ATE89744T1 - Pharmazeutische zusammensetzung. - Google Patents

Pharmazeutische zusammensetzung.

Info

Publication number
ATE89744T1
ATE89744T1 AT88302772T AT88302772T ATE89744T1 AT E89744 T1 ATE89744 T1 AT E89744T1 AT 88302772 T AT88302772 T AT 88302772T AT 88302772 T AT88302772 T AT 88302772T AT E89744 T1 ATE89744 T1 AT E89744T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
composition
pharmaceuticals
utilizes
nasal administration
Prior art date
Application number
AT88302772T
Other languages
English (en)
Inventor
Hanna R Kowarski
Original Assignee
Univ Temple
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Temple filed Critical Univ Temple
Application granted granted Critical
Publication of ATE89744T1 publication Critical patent/ATE89744T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT88302772T 1987-04-01 1988-03-29 Pharmazeutische zusammensetzung. ATE89744T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3332587A 1987-04-01 1987-04-01
EP88302772A EP0285367B1 (de) 1987-04-01 1988-03-29 Pharmazeutische Zusammensetzung

Publications (1)

Publication Number Publication Date
ATE89744T1 true ATE89744T1 (de) 1993-06-15

Family

ID=21869753

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88302772T ATE89744T1 (de) 1987-04-01 1988-03-29 Pharmazeutische zusammensetzung.

Country Status (5)

Country Link
EP (1) EP0285367B1 (de)
JP (1) JPH0717520B2 (de)
AT (1) ATE89744T1 (de)
CA (1) CA1335076C (de)
DE (1) DE3881254T2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1223132B (it) * 1987-11-13 1990-09-12 Isf Spa Composizione farmaceutica per somministrazione nasale
ES2061688T3 (es) * 1987-11-13 1994-12-16 Smithkline Beecham Farma Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
ES2089011T3 (es) * 1989-02-17 1996-10-01 Liposome Co Inc Excipiente lipidico de administracion nasal y aplicacion topica.
IT8920486A0 (it) * 1989-05-12 1989-05-12 Isf Spa Composizioni farmaceutiche.
IT1254321B (it) * 1992-04-10 1995-09-14 Kemiprogress S R L Composizione farmaceutica per il trattamento e la prevenzione delle infiammazioni cutanee e della mucosa orale.
AU681452B2 (en) * 1993-10-21 1997-08-28 Hisamitsu Pharmaceutical Co., Inc. Pernasal composition and pernasal preparation containing thesame

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1527605A (en) * 1975-08-20 1978-10-04 Takeda Chemical Industries Ltd Insulin preparation for intranasal administration
JPS5927978A (ja) * 1982-08-09 1984-02-14 Terumo Corp インドメタシン入り粘着テ−プ
US4476116A (en) * 1982-12-10 1984-10-09 Syntex (U.S.A.) Inc. Polypeptides/chelating agent nasal compositions having enhanced peptide absorption
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration

Also Published As

Publication number Publication date
DE3881254D1 (de) 1993-07-01
DE3881254T2 (de) 1993-09-02
EP0285367A2 (de) 1988-10-05
EP0285367A3 (en) 1990-03-14
EP0285367B1 (de) 1993-05-26
JPH0717520B2 (ja) 1995-03-01
CA1335076C (en) 1995-04-04
JPS63258821A (ja) 1988-10-26

Similar Documents

Publication Publication Date Title
DE3776946D1 (de) Nasale verabreichung von arzneimitteln.
PT88962A (pt) Aparelho aperfeicoado de libertacao transdermica de medicamentos
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
FI905718A0 (fi) Transdermalt medel.
DK414389D0 (da) Farmaceutisk praeparat indeholdende et aminosyrederivat med renin-inhibitorisk virkning
FI935728A (fi) Substituoituja 4-fenyylipyridoneja ja 4-fenyyli-2-alkoksipyridiinejä
AU1819288A (en) Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
HUT43494A (en) Process for producing pharmaceutical composition containing interferone-alpha
ATE94765T1 (de) Pharmazeutische praeparate zur verbesserten resorption antibakterieller verbindungen.
DE3881254D1 (de) Pharmazeutische zusammensetzung.
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
IE872667L (en) Pharmaceutical compositions
ATE59550T1 (de) Chlorpheniramine therapie.
AU2908389A (en) Device for administering medicaments by atomization in intubated or tracheotomized patients
IT1198238B (it) Composti ad attivita' antibiotica
MY101821A (en) Quinazolinediones and pyridopyrimidinediones
ATE89163T1 (de) Topisch anzuwendende diclofenac enthaltende arzneizubereitungen.
ATE96670T1 (de) Arzneimittel auf dextrorphanbasis zur intranasalen applikation.
IT1223132B (it) Composizione farmaceutica per somministrazione nasale
FR2694005B1 (fr) Nouvelles aminoalkylchromones, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
DK192487A (da) Carbiovasculaere farmaceutiske praeparater, som er egnet til topisk indgivning
EP0410652A3 (en) Improvement of excretion of potassium ion by prostanoic acid derivatives
ES8705888A1 (es) Procedimiento para preparar compuetos de imidazo-isoquino-leina y de imidazo-tienopiridina
SU1744810A1 (ru) Вазоактивное средство, нормализующее функции вегетативной нервной системы "димефосфон"
ATE78684T1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties